This exploratory study (Zaina et al., 2015, Archives of Environmental & Occupational Health) randomly sampled 48 of 273 former asbestos workers from a Veneto post-occupational surveillance program, all with heavy past exposure: mean exposure length 26.7Β±6.8 years, cumulative exposure 245.7Β±112.5 fiberΓyears/ml, peak exposure 87.6Β±60.6 f/ml, and 89% (42/48) with LDCT-diagnosed pleural plaques .
Urine (~60 ml/subject) was digested, filtered, and analyzed by SEM-EDS at 2000Γ magnification over 800 fields; "breathable fibers" were defined as length >5 Β΅m, diameter <3 Β΅m, aspect ratio >3 .
Of >5,000 detected elements, fibers were only 7.5% (405 fibers/ml vs 4970 particles/ml). Nonfibrous silicates (excluding vitreous) comprised ~50% of particles, with phyllosilicates the largest single group (29.8%); Ca-oxalates (20.2%) were considered likely endogenous .
Reported observation: Urinary asbestos fiber presence did not differ by age, length, cumulative or peak exposure, or time since exposure (Wilcoxon-Mann-Whitney and Fisher's exact tests, all non-significant) .
Key limitations: (1) No control group β the authors themselves acknowledge this prevents distinguishing occupational from environmental/background sources of urinary silicates; (2) small exploratory sample (n=48, 7 fiber-positive); (3) SEM-EDS cannot distinguish chrysotile from antigorite or tremolite from actinolite, so "asbestos" assignment partly rests on convention ; (4) the authors' exposure questionnaire, while validated in their earlier 772-worker cohort showing consistent dose-response with benign asbestos disease , is still semi-quantitative and retrospective. Notably, the null result (urine fails as an exposure or disease marker) argues against publication bias in this instance β a negative finding was published and honestly framed.
Context: The chrysotile dissolution half-life (~6 months) vs amphiboles (7β10 years) cited by the authors mechanistically explains why urine may reflect only recent or dissolution-derived material rather than cumulative lung burden . Broader asbestos literature (e.g., Wittenoom cohort predicting 250β680 mesothelioma deaths) confirms urine is not used for disease-risk prediction; LDCT-based surveillance, not urinary biomarkers, is where mortality-benefit evidence exists (HR lung cancer 0.41, 95% CI 0.17β0.96 in participants vs non-participants) .
Confidence note: The negative conclusion (urine SEM-EDS not a valid exposure/disease test) is well supported for this heavily exposed population; the positive hypothesis (urinary silicates as dissolution products of occupational origin) remains untested without controls.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.